Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

The role of betatrophin at onset of the Iraqi type II Diabetes Mellitus patients

Breadcrumb

  • Home
  • The Role of Betatrophin At Onset of The Iraqi Type II Diabetes Mellitus Patients
  • The role of betatrophin at onset of the Iraqi type II Diabetes Mellitus patients

Mustafa Saleam Khalaf 1, *, Sadik A Abdullah 2 and Ghufran Saad Nsaif 3

1 Department of Chemistry and Biochemistry, College of Medicine University of Fallujah, Anbar, Iraq.
2 Medical Laboratory Techniques Department, Al-Ma'moon University College, Baghdad, Iraq.
3 Department of Chemistry, College of Science, Baghdad University, Baghdad, Iraq.
 
Research Article
GSC Biological and Pharmaceutical Sciences, 2024, 29(01), 001-006.
Article DOI: 10.30574/gscbps.2024.29.1.0351
DOI url: https://doi.org/10.30574/gscbps.2024.29.1.0351
Received on 19 August 2024; revised on 28 September 2024; accepted on 30 September 2024
Background: Type II diabetes mellitus It is one of the most important metabolic disorders that the body suffers from, which affects glucose metabolism. It begins first with insulin resistance and then develops into type II diabetes mellitus disorder. One of the most famous pathological complications of type II diabetes mellitus disorder is the inhibition of insulin secretion and hyperlipidemia. Betatrophin which is a protein hormone produced at the beginning of infection with type II diabetes mellitus disorder. It works as a protective factor as it activates the growth and development of pancreatic beta cells and also has a role in regulating lipid metabolism at the beginning of infection with the disorder. 
Materials and methods: The present study included the selection of 28 individuals suffering from type II diabetes mellitus disorder, and 28 healthy individuals as control. The study individuals were of both sexes and their ages ranged between 38-55 years. Many of biochemical markers were measured for all study individuals include Insulin hormone, random blood sugar, glycated hemoglobin, Betatrophin hormone and C-peptide, where special kits from the best international companies were used for this. On the other hand, the t-test method was used for statistical analysis to compare the two groups.
 Results: After comparing the control group with the patients group with type II diabetes mellitus disorder, it was found that there was elevate in the levels of random blood sugar, glycated hemoglobin, Betatrophin hormone and C-peptide in the group of patients compared to the control group, except insulin hormone which was not affected. The values ​​of mean ± standard deviation (SD) and p-value were relied upon to determine the clinically significant values.
Conclusion: The current study results conclude that the hormone Betatrophin begins to rise as a protective factor for the body at the onset of insulin resistance, which causes with type II diabetes mellitus disorder This increase in the level of the hormone Betatrophin is an attempt by the body to rebuild parts of the pancreas to enhance insulin secretion and also to regulate the metabolism of fat in the body, which is considered a complication of with type II diabetes mellitus disorder
Betatrophin; Type II diabetes mellitus disorder; Insulin resistance
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2024-…

Preview Article PDF

Mustafa Saleam Khalaf, Sadik A Abdullah and Ghufran Saad Nsaif. The role of betatrophin at onset of the Iraqi type II Diabetes Mellitus patients. GSC Biological and Pharmaceutical Sciences, 2024, 29(1), 001-006. Article DOI: https://doi.org/10.30574/gscbps.2024.29.1.0351


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution